Clarivate Plc (NYSE:CLVT – Get Free Report) was the recipient of a large drop in short interest in August. As of August 31st, there was short interest totalling 26,460,000 shares, a drop of 9.9% from the August 15th total of 29,370,000 shares. Currently, 6.2% of the company’s stock are sold short. Based on an average daily volume of 4,380,000 shares, the days-to-cover ratio is currently 6.0 days.
Clarivate Stock Performance
NYSE:CLVT traded down $0.04 during midday trading on Tuesday, reaching $6.64. 2,185,606 shares of the company traded hands, compared to its average volume of 4,343,918. Clarivate has a twelve month low of $4.97 and a twelve month high of $9.60. The firm has a market capitalization of $4.44 billion, a price-to-earnings ratio of -4.00, a price-to-earnings-growth ratio of 3.24 and a beta of 1.17. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.90 and a quick ratio of 0.90. The company has a fifty day moving average price of $6.39 and a 200 day moving average price of $6.45.
Clarivate (NYSE:CLVT – Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.02. Clarivate had a positive return on equity of 10.01% and a negative net margin of 46.53%. The business had revenue of $650.30 million during the quarter, compared to analyst estimates of $651.94 million. During the same quarter in the previous year, the firm posted $0.16 EPS. The business’s revenue for the quarter was down 2.8% compared to the same quarter last year. On average, analysts expect that Clarivate will post 0.64 EPS for the current fiscal year.
Insider Buying and Selling at Clarivate
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in CLVT. SG Americas Securities LLC acquired a new stake in shares of Clarivate in the second quarter valued at $1,410,000. Edmond DE Rothschild Holding S.A. acquired a new stake in shares of Clarivate in the fourth quarter valued at $25,576,000. Glenview Capital Management LLC lifted its holdings in shares of Clarivate by 22.2% in the fourth quarter. Glenview Capital Management LLC now owns 24,651,047 shares of the company’s stock valued at $228,269,000 after buying an additional 4,472,302 shares during the period. Capital World Investors acquired a new stake in shares of Clarivate in the first quarter valued at $30,104,000. Finally, Confluence Investment Management LLC acquired a new stake in shares of Clarivate in the first quarter valued at $18,389,000. Institutional investors and hedge funds own 85.72% of the company’s stock.
Wall Street Analysts Forecast Growth
CLVT has been the subject of several research reports. Royal Bank of Canada decreased their target price on Clarivate from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Wednesday, August 7th. Barclays decreased their target price on Clarivate from $6.00 to $5.00 and set an “underweight” rating for the company in a research report on Wednesday, August 7th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $7.75.
Get Our Latest Research Report on Clarivate
About Clarivate
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
See Also
- Five stocks we like better than Clarivate
- 5 Top Rated Dividend Stocks to Consider
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Airline Stocks – Top Airline Stocks to Buy Now
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What Does Downgrade Mean in Investing?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.